SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                                    FORM 8-K

                                 CURRENT REPORT



     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

        Date of Report (Date of earliest event reported): March 24, 2005

                        Commission File Number: 000-21376


                               Bio-Life Labs, Inc.
                               -------------------
             (Exact name of registrant as specified in its charter)


Nevada                                                               33-0714007
------                                                               ----------
(State or other jurisdiction of            (I.R.S. Employer Identification No.)
incorporation or organization)

16 Concord Rd., El Paso, TX 79906                                         79906
---------------------------------                                         -----
(Address of principal executive offices)                             (Zip Code)


                                 (915) 843-2044
                                 --------------
              (Registrant's Telephone Number, Including Area Code)




<PAGE>


ITEM 8.01:  OTHER EVENTS

Bio-Life Labs, Inc., a Nevada  corporation (the "Registrant") has entered into a
Settlement  Agreement  dated March 23, 2005 that settles and releases all claims
against the  Company;  its CEO,  President  and Chairman  Nancy  LeMay;  and its
Executive Vice President and Director David Karam, M.D., Ph.D. by Plaintiff Zach
Thomas who was  seeking to enforce an alleged  oral  agreement  with Dr.  Karam.
Plaintiff Thomas alleged that Dr. Karam agreed to issue Plaintiff Thomas 25 % of
his personal equity in Bio-Life Labs, Inc.

Under the terms of the Settlement, Dr. Karam agreed to issue 20% (5,921,932) of
his personally-owned shares of common stock to the Plaintiffs.







<PAGE>



                                   SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.




March 27, 2005                              Bio-Life Labs, Inc.




                                       By:  /s/ Nancy LeMay
                                            --------------------------------
                                            Nancy LeMay, President
[{"type": "8-K", "sequence": "1", "filename": "biolife-8k.txt", "secsgml_size_bytes": 2483}]
{"company-data": {"conformed-name": "BIO-LIFE LABS INC.", "cik": "0000899049", "assigned-sic": "7812", "irs-number": "330714007", "fiscal-year-end": "0630"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-30546", "film-number": "05713479"}, "business-address": {"street1": "9911 WEST PICO BLVD", "street2": "SUITE 1410", "city": "LOS ANGELES", "state": "CA", "zip": "90035", "phone": "310-943-6445"}, "mail-address": {"street1": "9911 WEST PICO BLVD", "street2": "SUITE 1410", "city": "LOS ANGELES", "state": "CA", "zip": "90035"}, "former-company": [{"former-conformed-name": "TECSCAN INTERNATIONAL INC", "date-changed": "20030625"}, {"former-conformed-name": "PHOENIX MEDIA GROUP LTD", "date-changed": "20000121"}, {"former-conformed-name": "NATURAL SOLUTIONS LTD", "date-changed": "19930319"}]}
SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

        Date of Report (Date of earliest event reported): March 24, 2005

                        Commission File Number: 000-21376

                               Bio-Life Labs, Inc.
                               -------------------
             (Exact name of registrant as specified in its charter)

Nevada                                                               33-0714007
------                                                               ----------
(State or other jurisdiction of            (I.R.S. Employer Identification No.)
incorporation or organization)

16 Concord Rd., El Paso, TX 79906                                         79906
---------------------------------                                         -----
(Address of principal executive offices)                             (Zip Code)

                                 (915) 843-2044
                                 --------------
              (Registrant's Telephone Number, Including Area Code)
ITEM 8.01:  OTHER EVENTS

Bio-Life Labs, Inc., a Nevada  corporation (the "Registrant") has entered into a
Settlement  Agreement  dated March 23, 2005 that settles and releases all claims
against the  Company;  its CEO,  President  and Chairman  Nancy  LeMay;  and its
Executive Vice President and Director David Karam, M.D., Ph.D. by Plaintiff Zach
Thomas who was  seeking to enforce an alleged  oral  agreement  with Dr.  Karam.
Plaintiff Thomas alleged that Dr. Karam agreed to issue Plaintiff Thomas 25 % of
his personal equity in Bio-Life Labs, Inc.

Under the terms of the Settlement, Dr. Karam agreed to issue 20% (5,921,932) of
his personally-owned shares of common stock to the Plaintiffs.
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.

March 27, 2005                              Bio-Life Labs, Inc.

                                       By:  /s/ Nancy LeMay
                                            --------------------------------
                                            Nancy LeMay, President